Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-07-11 Sale | 2024-07-15 5:29 pm | ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer | 11,945 | $15.97 | $190,747 | 102,342 (Direct) | View |
| 2024-06-17 Sale | 2024-06-17 8:38 pm | ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Chief Product Strategy Officer | 7,266 | $12.33 | $89,590 | 32,341 (Direct) | View |
| 2023-12-13 Sale | 2023-12-15 8:08 pm | ENANTA PHARMACEUTICALS INC | ENTA | Vance Terry Director | 15,295 | $9.12 | $139,490 | 5,800 (Direct) | View |
| 2023-12-05 Sale | 2023-12-06 8:31 pm | ENANTA PHARMACEUTICALS INC | ENTA | Luu Brendan Sr. VP, Business Dev. | 2,125 | $9.63 | $20,464 | 36,736 (Direct) | View |
| 2023-12-05 Sale | 2023-12-06 8:29 pm | ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Sr. VP, New Prod. Strat. & Dev | 2,125 | $9.63 | $20,464 | 37,260 (Direct) | View |
| 2023-12-05 Sale | 2023-12-06 8:26 pm | ENANTA PHARMACEUTICALS INC | ENTA | Gardiner Nathaniel S. Sr. VP & General Counsel | 2,412 | $9.63 | $23,228 | 104,080 (Indirect Direct) | View |
| 2023-12-05 Sale | 2023-12-06 8:24 pm | ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Sr. VP & CMO | 534 | $9.63 | $5,142 | 26,466 (Direct) | View |
| 2023-12-05 Sale | 2023-12-06 8:22 pm | ENANTA PHARMACEUTICALS INC | ENTA | Or Yat Sun Sr. VP, R&D & CSO | 2,412 | $9.63 | $23,228 | 370,695 (Direct) | View |
| 2023-12-05 Sale | 2023-12-06 8:19 pm | ENANTA PHARMACEUTICALS INC | ENTA | MELLETT PAUL J Sr. VP, Finance & Admin. & CFO | 2,412 | $9.63 | $23,228 | 93,549 (Direct) | View |
| 2023-12-05 Sale | 2023-12-06 8:17 pm | ENANTA PHARMACEUTICALS INC | ENTA | Luly Jay R. President and CEO | 7,230 | $9.63 | $69,625 | 806,793 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-08 Tax Withholding | 2024-08-09 5:24 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer | 1,466 | $12.73 | 18,784 (Direct) | View |
| 2023-08-08 Tax Withholding | 2024-08-09 5:24 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer | 1,467 | $17.23 | 18,784 (Direct) | View |
| 2024-07-15 Exercise | 2024-07-15 5:29 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer | 5,375 | $8.99 | 102,342 (Direct) | View |
| 2024-07-15 Exercise | 2024-07-15 5:29 pm | N/A 2033-11-22 | ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer | 5,375 | $0 | 102,342 (Direct) | View |
| 2024-04-29 Option Award | 2024-05-01 4:27 pm | N/A 2034-04-29 | ENANTA PHARMACEUTICALS INC | ENTA | Kowalsky Matthew Paul Chief Legal Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2024-03-06 Option Award | 2024-03-08 5:30 pm | N/A 2034-03-06 | ENANTA PHARMACEUTICALS INC | ENTA | Vance Terry Director | 15,700 | $0 | 15,700 (Direct) | View |
| 2024-03-06 Option Award | 2024-03-08 5:27 pm | N/A 2034-03-06 | ENANTA PHARMACEUTICALS INC | ENTA | Russell Lesley Director | 15,700 | $0 | 15,700 (Direct) | View |
| 2024-03-06 Option Award | 2024-03-08 5:23 pm | N/A 2034-03-06 | ENANTA PHARMACEUTICALS INC | ENTA | Peterson Kristine Director | 15,700 | $0 | 15,700 (Direct) | View |
| 2024-03-06 Option Award | 2024-03-08 5:19 pm | N/A 2034-03-06 | ENANTA PHARMACEUTICALS INC | ENTA | Hata Yujiro S Director | 15,700 | $0 | 15,700 (Direct) | View |
| 2024-03-06 Option Award | 2024-03-08 5:15 pm | N/A 2034-03-06 | ENANTA PHARMACEUTICALS INC | ENTA | FOLETTA MARK G Director | 15,700 | $0 | 15,700 (Direct) | View |
| 2024-03-06 Option Award | 2024-03-08 5:12 pm | N/A 2034-03-06 | ENANTA PHARMACEUTICALS INC | ENTA | CARTER BRUCE L A Director | 15,700 | $0 | 15,700 (Direct) | View |
| 2024-02-26 Exercise | 2024-02-27 6:31 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Gardiner Nathaniel S. Chief Legal Officer | 5,187 | $8.99 | 189,427 (Direct) | View |
| 2024-02-26 Exercise | 2024-02-27 6:31 pm | N/A 2033-11-22 | ENANTA PHARMACEUTICALS INC | ENTA | Gardiner Nathaniel S. Chief Legal Officer | 5,187 | $0 | 189,427 (Direct) | View |
| 2024-02-12 Option Award | 2024-02-14 8:23 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Luu Brendan Chief Business Officer | 3,320 | $0 | 39,083 (Direct) | View |
| 2024-02-12 Tax Withholding | 2024-02-14 8:23 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Luu Brendan Chief Business Officer | 973 | $12.41 | 39,083 (Direct) | View |
| 2024-02-12 Option Award | 2024-02-14 8:21 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Chief Product Strategy Officer | 3,320 | $0 | 39,607 (Direct) | View |
| 2024-02-12 Tax Withholding | 2024-02-14 8:21 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Chief Product Strategy Officer | 973 | $12.41 | 39,607 (Direct) | View |
| 2024-02-12 Option Award | 2024-02-14 8:18 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Gardiner Nathaniel S. Chief Legal Officer | 3,320 | $0 | 106,427 (Direct) | View |
| 2024-02-12 Tax Withholding | 2024-02-14 8:18 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Gardiner Nathaniel S. Chief Legal Officer | 973 | $12.41 | 106,427 (Direct) | View |
| 2024-02-12 Option Award | 2024-02-14 8:15 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer | 2,576 | $0 | 28,287 (Direct) | View |
| 2024-02-12 Tax Withholding | 2024-02-14 8:15 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer | 755 | $12.41 | 28,287 (Direct) | View |
| 2024-02-12 Option Award | 2024-02-14 8:12 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Or Yat Sun Chief Scientific Officer | 3,680 | $0 | 373,295 (Direct) | View |
| 2024-02-12 Tax Withholding | 2024-02-14 8:12 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Or Yat Sun Chief Scientific Officer | 1,080 | $12.41 | 373,295 (Direct) | View |
| 2024-02-12 Option Award | 2024-02-14 8:09 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | MELLETT PAUL J Chief Fin. & Admin Officer | 3,320 | $0 | 95,896 (Direct) | View |
| 2024-02-12 Tax Withholding | 2024-02-14 8:09 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | MELLETT PAUL J Chief Fin. & Admin Officer | 973 | $12.41 | 95,896 (Direct) | View |
| 2024-02-12 Option Award | 2024-02-14 8:00 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Luly Jay R. President and CEO | 5,400 | $0 | 810,609 (Direct) | View |
| 2024-02-12 Tax Withholding | 2024-02-14 8:00 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Luly Jay R. President and CEO | 1,584 | $12.41 | 810,609 (Direct) | View |
| 2023-12-01 Tax Withholding | 2023-12-05 9:24 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Luu Brendan Sr. VP, Business Dev. | 753 | $9.49 | 38,861 (Direct) | View |
| 2023-12-01 Tax Withholding | 2023-12-05 9:21 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Sr. VP, New Prod. Strat. & Dev | 753 | $9.49 | 39,385 (Direct) | View |
| 2023-12-01 Tax Withholding | 2023-12-05 9:19 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Gardiner Nathaniel S. Sr. VP & General Counsel | 1,595 | $9.49 | 106,492 (Direct) | View |
| 2023-12-01 Tax Withholding | 2023-12-05 9:15 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Or Yat Sun Sr. VP, R&D & CSO | 1,595 | $9.49 | 373,107 (Direct) | View |
| 2023-12-01 Tax Withholding | 2023-12-05 9:11 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | MELLETT PAUL J Sr. VP, Finance & Admin. & CFO | 1,595 | $9.49 | 95,961 (Direct) | View |
| 2023-12-01 Tax Withholding | 2023-12-05 9:08 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Luly Jay R. President and CEO | 5,787 | $9.49 | 814,023 (Direct) | View |
| 2023-11-22 Option Award | 2023-11-22 5:12 pm | N/A 2033-11-22 | ENANTA PHARMACEUTICALS INC | ENTA | Luu Brendan Sr. VP, Business Dev. | 83,000 | $0 | 83,000 (Direct) | View |
| 2023-11-22 Option Award | 2023-11-22 5:12 pm | N/A 2033-11-22 | ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Sr. VP, New Prod. Strat. & Dev | 83,000 | $0 | 83,000 (Direct) | View |
| 2023-11-22 Option Award | 2023-11-22 5:12 pm | N/A 2033-11-22 | ENANTA PHARMACEUTICALS INC | ENTA | MELLETT PAUL J Sr. VP, Finance & Admin. & CFO | 83,000 | $0 | 83,000 (Direct) | View |
| 2023-11-22 Option Award | 2023-11-22 5:11 pm | N/A 2033-11-22 | ENANTA PHARMACEUTICALS INC | ENTA | Gardiner Nathaniel S. Sr. VP & General Counsel | 83,000 | $0 | 83,000 (Direct) | View |
| 2023-11-22 Option Award | 2023-11-22 5:11 pm | N/A 2033-11-22 | ENANTA PHARMACEUTICALS INC | ENTA | Or Yat Sun Sr. VP, R&D & CSO | 86,000 | $0 | 86,000 (Direct) | View |
| 2023-11-22 Option Award | 2023-11-22 5:10 pm | N/A 2033-11-22 | ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Sr. VP & CMO | 86,000 | $0 | 86,000 (Direct) | View |
| 2023-11-22 Option Award | 2023-11-22 5:10 pm | N/A 2033-11-22 | ENANTA PHARMACEUTICALS INC | ENTA | Luly Jay R. President and CEO | 264,000 | $0 | 264,000 (Direct) | View |